ANNALISE MABE: Open Payments
NPI 1528684990 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 91 payments from 16 companies in 2025. Trend: 2023 $1,032 · 2024 $1,588 · 2025 $1,697
Food & beverage: $1,548Education: $149
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $429 |
| ABBVIE INC. | 14 | $353 |
| Lilly USA, LLC | 10 | $181 |
| Galderma Laboratories, L.P. | 12 | $148 |
| UCB, Inc. | 5 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| GENZYME CORPORATION | 3 | $68 |
| LEO Pharma Inc. | 1 | $21 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, EBGLYSS, NEMLUVIO, Bimzelx, RINVOQ, COSENTYX.
Industry payments across ID — which companies pay providers there.
